DiagnaMed Holdings Corp. (TSE:DMED) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
DiagnaMed Holdings Corp. has introduced CERVAI™, an innovative AI-driven brain health assessment tool, at the University of Miami Comprehensive Center for Brain Health. The technology aims to predict Alzheimer’s disease and other neurological conditions by evaluating a person’s brain resilience and performance. It has been clinically validated and shows a high accuracy rate in identifying cognitive impairment in a recent study.
For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.
